 | • レポートコード：QYR9ST05347 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、尿路上皮がん薬の世界市場について調査・分析し、尿路上皮がん薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、免疫療法）、用途別（病院、薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の尿路上皮がん薬市場動向 ・主要企業別マーケットシェア ・尿路上皮がん薬の種類別市場規模2014-2019 （化学療法、免疫療法） ・尿路上皮がん薬の用途別市場規模2014-2019 （病院、薬局） ・尿路上皮がん薬の北米市場：主要企業・種類別/用途別市場規模 ・尿路上皮がん薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・尿路上皮がん薬の中国市場：主要企業・種類別/用途別市場規模 ・尿路上皮がん薬の日本国内市場：主要企業・種類別/用途別市場規模 ・尿路上皮がん薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・尿路上皮がん薬のインド市場：主要企業・種類別/用途別市場規模 ・尿路上皮がん薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Roche、Merck、Bristol-Myers Squibb、AstraZeneca、Pfizer） ・尿路上皮がん薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounted for approximately 90% of all urinary cancer cases.Market growth is largely attributed to factors such as availability of novel drugs, presence of a strong pipeline, rise in incidence of urothelial cancer due to growing geriatric population, unorganized lifestyle, and rising public awareness.
In 2018, the global Urothelial Cancer Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Urothelial Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Urothelial Cancer Drugs development in United States, Europe and China.
The key players covered in this study
Roche
Merck
Bristol-Myers Squibb
AstraZeneca
Pfizer
…
Market segment by Type, the product can be split into
Chemotherapy
Immunotherapy
Market segment by Application, split into
Hospitals
Pharmacy
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Urothelial Cancer Drugs status, future forecast, growth opportunity, key market and key players.
To present the Urothelial Cancer Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Urothelial Cancer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Urothelial Cancer Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Immunotherapy
1.5 Market by Application
1.5.1 Global Urothelial Cancer Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Urothelial Cancer Drugs Market Size
2.2 Urothelial Cancer Drugs Growth Trends by Regions
2.2.1 Urothelial Cancer Drugs Market Size by Regions (2014-2025)
2.2.2 Urothelial Cancer Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Urothelial Cancer Drugs Market Size by Manufacturers
3.1.1 Global Urothelial Cancer Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Urothelial Cancer Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Urothelial Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Urothelial Cancer Drugs Key Players Head office and Area Served
3.3 Key Players Urothelial Cancer Drugs Product/Solution/Service
3.4 Date of Enter into Urothelial Cancer Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Urothelial Cancer Drugs Market Size by Type (2014-2019)
4.2 Global Urothelial Cancer Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Urothelial Cancer Drugs Market Size (2014-2019)
5.2 Urothelial Cancer Drugs Key Players in United States
5.3 United States Urothelial Cancer Drugs Market Size by Type
5.4 United States Urothelial Cancer Drugs Market Size by Application
6 Europe
6.1 Europe Urothelial Cancer Drugs Market Size (2014-2019)
6.2 Urothelial Cancer Drugs Key Players in Europe
6.3 Europe Urothelial Cancer Drugs Market Size by Type
6.4 Europe Urothelial Cancer Drugs Market Size by Application
7 China
7.1 China Urothelial Cancer Drugs Market Size (2014-2019)
7.2 Urothelial Cancer Drugs Key Players in China
7.3 China Urothelial Cancer Drugs Market Size by Type
7.4 China Urothelial Cancer Drugs Market Size by Application
8 Japan
8.1 Japan Urothelial Cancer Drugs Market Size (2014-2019)
8.2 Urothelial Cancer Drugs Key Players in Japan
8.3 Japan Urothelial Cancer Drugs Market Size by Type
8.4 Japan Urothelial Cancer Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Urothelial Cancer Drugs Market Size (2014-2019)
9.2 Urothelial Cancer Drugs Key Players in Southeast Asia
9.3 Southeast Asia Urothelial Cancer Drugs Market Size by Type
9.4 Southeast Asia Urothelial Cancer Drugs Market Size by Application
10 India
10.1 India Urothelial Cancer Drugs Market Size (2014-2019)
10.2 Urothelial Cancer Drugs Key Players in India
10.3 India Urothelial Cancer Drugs Market Size by Type
10.4 India Urothelial Cancer Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Urothelial Cancer Drugs Market Size (2014-2019)
11.2 Urothelial Cancer Drugs Key Players in Central & South America
11.3 Central & South America Urothelial Cancer Drugs Market Size by Type
11.4 Central & South America Urothelial Cancer Drugs Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Urothelial Cancer Drugs Introduction
12.1.4 Roche Revenue in Urothelial Cancer Drugs Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Urothelial Cancer Drugs Introduction
12.2.4 Merck Revenue in Urothelial Cancer Drugs Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Urothelial Cancer Drugs Introduction
12.3.4 Bristol-Myers Squibb Revenue in Urothelial Cancer Drugs Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Company Details
12.4.2 Company Description and Business Overview
12.4.3 Urothelial Cancer Drugs Introduction
12.4.4 AstraZeneca Revenue in Urothelial Cancer Drugs Business (2014-2019)
12.4.5 AstraZeneca Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Urothelial Cancer Drugs Introduction
12.5.4 Pfizer Revenue in Urothelial Cancer Drugs Business (2014-2019)
12.5.5 Pfizer Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Urothelial Cancer Drugs Key Market Segments
Table Key Players Urothelial Cancer Drugs Covered
Table Global Urothelial Cancer Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Urothelial Cancer Drugs Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Immunotherapy Figures
Table Key Players of Immunotherapy
Table Global Urothelial Cancer Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Pharmacy Case Studies
Figure Urothelial Cancer Drugs Report Years Considered
Table Global Urothelial Cancer Drugs Market Size 2014-2025 (Million US$)
Figure Global Urothelial Cancer Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Urothelial Cancer Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Urothelial Cancer Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Urothelial Cancer Drugs Market Share by Regions 2014-2019
Figure Global Urothelial Cancer Drugs Market Share by Regions 2014-2019
Figure Global Urothelial Cancer Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Urothelial Cancer Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Urothelial Cancer Drugs Market Share by Manufacturers (2014-2019)
Figure Global Urothelial Cancer Drugs Market Share by Manufacturers in 2018
Table Global Urothelial Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Urothelial Cancer Drugs Product/Solution/Service
Table Date of Enter into Urothelial Cancer Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Urothelial Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Urothelial Cancer Drugs Market Size Share by Type (2014-2019)
Figure Global Urothelial Cancer Drugs Market Size Market Share by Type (2014-2019)
Table Global Urothelial Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Urothelial Cancer Drugs Market Size Share by Application (2014-2019)
Figure Global Urothelial Cancer Drugs Market Size Market Share by Application (2014-2019)
Figure Global Urothelial Cancer Drugs Revenue Market Share by Application in 2018
Figure United States Urothelial Cancer Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Urothelial Cancer Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Urothelial Cancer Drugs Market Share (2018-2019)
Table United States Urothelial Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Urothelial Cancer Drugs Market Share by Type (2014-2019)
Table United States Urothelial Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Urothelial Cancer Drugs Market Share by Application (2014-2019)
Figure Europe Urothelial Cancer Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Urothelial Cancer Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Urothelial Cancer Drugs Market Share (2018-2019)
Table Europe Urothelial Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Urothelial Cancer Drugs Market Share by Type (2014-2019)
Table Europe Urothelial Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Urothelial Cancer Drugs Market Share by Application (2014-2019)
Figure China Urothelial Cancer Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Urothelial Cancer Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Urothelial Cancer Drugs Market Share (2018-2019)
Table China Urothelial Cancer Drugs Market Size by Type (2014-20189) (Million US$)
Table China Urothelial Cancer Drugs Market Share by Type (2014-2019)
Table China Urothelial Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table China Urothelial Cancer Drugs Market Share by Application (2014-2019)
Figure Japan Urothelial Cancer Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Urothelial Cancer Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Urothelial Cancer Drugs Market Share (2018-2019)
Table Japan Urothelial Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Urothelial Cancer Drugs Market Share by Type (2014-2019)
Table Japan Urothelial Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Urothelial Cancer Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Urothelial Cancer Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Urothelial Cancer Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Urothelial Cancer Drugs Market Share (2018-2019)
Table Southeast Asia Urothelial Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Urothelial Cancer Drugs Market Share by Type (2014-2019)
Table Southeast Asia Urothelial Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Urothelial Cancer Drugs Market Share by Application (2014-2019)
Figure India Urothelial Cancer Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Urothelial Cancer Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Urothelial Cancer Drugs Market Share (2018-2019)
Table India Urothelial Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table India Urothelial Cancer Drugs Market Share by Type (2014-2019)
Table India Urothelial Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table India Urothelial Cancer Drugs Market Share by Application (2014-2019)
Figure Central & South America Urothelial Cancer Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Urothelial Cancer Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Urothelial Cancer Drugs Market Share (2018-2019)
Table Central & South America Urothelial Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Urothelial Cancer Drugs Market Share by Type (2014-2019)
Table Central & South America Urothelial Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Urothelial Cancer Drugs Market Share by Application (2014-2019)
Table Roche Company Details
Table Roche Revenue in Urothelial Cancer Drugs Business (2014-2019) (Million US$)
Figure Roche Revenue Growth Rate in Urothelial Cancer Drugs Business (2014-2019)
Table Roche Recent Development
Table Merck Company Details
Table Merck Revenue in Urothelial Cancer Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Urothelial Cancer Drugs Business (2014-2019)
Table Merck Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Urothelial Cancer Drugs Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Urothelial Cancer Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Urothelial Cancer Drugs Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Urothelial Cancer Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Urothelial Cancer Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Urothelial Cancer Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Global Urothelial Cancer Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Urothelial Cancer Drugs Market Size Share by Regions (2019-2025)
Figure Global Urothelial Cancer Drugs Market Size Share by Regions in 2025
Figure United States Urothelial Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Urothelial Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Urothelial Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Urothelial Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Urothelial Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Urothelial Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Urothelial Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Urothelial Cancer Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Urothelial Cancer Drugs Market Size by Product (2019-2025)
Figure Global Urothelial Cancer Drugs Market Size by Product in 2025
Table Global Urothelial Cancer Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Urothelial Cancer Drugs Market Size by Application (2019-2025)
Figure Global Urothelial Cancer Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
尿路上皮がん薬の世界市場：市場規模・現状・予測 Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounte…- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- がん支持療法薬の世界市場：市場規模・現状・予測 Supportive drugs are not anticancer drugs. They protect certain cells or organs from the side effects of chemotherapy drugs or radiation therapy.Increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailored…
- 前立腺癌治療薬の世界市場：市場規模・現状・予測 Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players ar…